Familial Cancer最新文献

筛选
英文 中文
Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case report. Birt-Hogg-Dubé 综合征患者小于 3 厘米的肾细胞癌切除术后的转移性疾病病例报告。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-11-01 Epub Date: 2024-06-20 DOI: 10.1007/s10689-024-00408-w
L van Riel, C M Kets, L P van Hest, F H Menko, B G Boerrigter, S M Franken, R M F Wolthuis, H J Dubbink, P J Zondervan, R J A van Moorselaar, A C Houweling, I van de Beek
{"title":"Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case report.","authors":"L van Riel, C M Kets, L P van Hest, F H Menko, B G Boerrigter, S M Franken, R M F Wolthuis, H J Dubbink, P J Zondervan, R J A van Moorselaar, A C Houweling, I van de Beek","doi":"10.1007/s10689-024-00408-w","DOIUrl":"10.1007/s10689-024-00408-w","url":null,"abstract":"","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"579-582"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 17th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC) : May 23-24, 2023 Rockville, Maryland, United States. 第 17 届遗传性癌症社会心理问题国际会议(IMPAHC) :2023年5月23-24日,美国马里兰州罗克维尔。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-11-01 DOI: 10.1007/s10689-024-00396-x
{"title":"The 17th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC) : May 23-24, 2023 Rockville, Maryland, United States.","authors":"","doi":"10.1007/s10689-024-00396-x","DOIUrl":"10.1007/s10689-024-00396-x","url":null,"abstract":"","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"675-702"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141418519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery. 癌症风险评估的数字化创新使地区癌症遗传学服务得以大规模重新发展。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-11-01 Epub Date: 2024-07-01 DOI: 10.1007/s10689-024-00407-x
Alice Youngs, Andrea Forman, Marisa Elms, Kelly Kohut, Min Theik Hlaing, John Short, Helen Hanson, Katie Snape
{"title":"Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery.","authors":"Alice Youngs, Andrea Forman, Marisa Elms, Kelly Kohut, Min Theik Hlaing, John Short, Helen Hanson, Katie Snape","doi":"10.1007/s10689-024-00407-x","DOIUrl":"10.1007/s10689-024-00407-x","url":null,"abstract":"<p><p>Family-history assessment can identify individuals above population-risk for cancer to enable targeted Screening, Prevention and Early Detection (SPED). The online patient-facing cancer Family History Questionnaire Service (cFHQS) is a digitalised, resource efficient tool for family history data capture to facilitate this. The capturing of digital data from cFHQS allows for data interrogation of patients referred to Clinical Genetics for the purposes of service improvement. Digital data from 4,044 cFHQS respondents over a three-year period was collected and interrogated with respect to the number and type of familial tumour diagnoses to enable service improvement and streamlining of referral pathways. 81% of colorectal and 71% of breast screening assessments were population- or moderate-risk. Most patients who completed cFHQS reported more than one diagnosis of cancer/tumour/polyps in their family. 2.5% of family history assessment patients had a second indication that required assessment that would have been missed if single tumour type assessment was undertaken. Implementation of an innovative, digital family history data collection pathway has allowed large scale interrogation of referral patterns and assessment outcomes to enable service development. The high volume of inappropriate referrals to Clinical Genetics for population and moderate risk patients highlighted the need for dedicated secondary care pathway provision for these patients. The use of cFHQS streamlined family history assessment allows for redistribution of resources to improve equity and access to genetic cancer risk assessment.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"591-598"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications of colonoscopy surveillance of patients with Lynch syndrome - 33 years of follow up. 林奇综合征患者结肠镜检查监测并发症 - 33 年的随访。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-11-01 DOI: 10.1007/s10689-024-00416-w
Alexander Frank, Sophie Walton Bernstedt, Nigin Jamizadeh, Anna Forsberg, Charlotte Hedin, Johannes Blom, Ann-Sofie Backman
{"title":"Complications of colonoscopy surveillance of patients with Lynch syndrome - 33 years of follow up.","authors":"Alexander Frank, Sophie Walton Bernstedt, Nigin Jamizadeh, Anna Forsberg, Charlotte Hedin, Johannes Blom, Ann-Sofie Backman","doi":"10.1007/s10689-024-00416-w","DOIUrl":"10.1007/s10689-024-00416-w","url":null,"abstract":"<p><strong>Background and study aims: </strong>Lynch syndrome (LS) is a hereditary autosomal dominant condition, with an increased lifetime risk of developing malignancies including colorectal cancer (CRC). Current guidelines differ in recommended colonoscopy-surveillance intervals from 1 to 2 years. Although colonoscopy is considered a safe procedure, there are risks of severe adverse events (SAEs), such as perforation and bleeding, as well as adverse events (AEs), such as abdominal discomfort and post-colonoscopy gastrointestinal infections. Colonoscopy-related bleeding and perforation rates have been reported 0.17% and 0.11%, respectively. However, there are insufficient data regarding complications of colonoscopy-surveillance for LS patients. This study aims to investigate the risk of AEs among LS patients during colonoscopy in the Stockholm region.</p><p><strong>Patients and methods: </strong>This retrospective cohort study includes 351 LS patients undergoing endoscopic surveillance at the Karolinska University Hospital, August 1989 - April 2021. Data from endoscopic surveillance colonoscopies were extracted from patients' medical records.</p><p><strong>Results: </strong>Of 1873 endoscopies in 351 LS patients, 12 complications (AEs) were documented within 30 days (0.64%) and with a total of 3 bleedings (SAEs, 0.16%). No perforations were identified.</p><p><strong>Conclusion: </strong>Colonoscopy surveillance for LS patients shows a comparatively low risk of AEs per-examination. Colonoscopy complications per-patient, including both SAEs and AEs, show a significantly higher risk. Colonoscopy complications only including SAEs, show a comparatively low risk. Understanding the lifetime risk of surveillance-related colonoscopy complications is important when designing targeted surveillance programmes.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"599-605"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High amount of fertility reducing tumors and procedures, but no evidence for premature ovarian failure in female Lynch syndrome patients. 大量减少生育能力的肿瘤和手术,但没有证据表明女性林奇综合征患者会出现卵巢早衰。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-11-01 Epub Date: 2024-01-27 DOI: 10.1007/s10689-024-00357-4
Sabine Biermann, Michael Knapp, Peter Wieacker, Stefan Aretz, Verena Steinke-Lange
{"title":"High amount of fertility reducing tumors and procedures, but no evidence for premature ovarian failure in female Lynch syndrome patients.","authors":"Sabine Biermann, Michael Knapp, Peter Wieacker, Stefan Aretz, Verena Steinke-Lange","doi":"10.1007/s10689-024-00357-4","DOIUrl":"10.1007/s10689-024-00357-4","url":null,"abstract":"<p><p>Lynch syndrome (LS; HNPCC) patients carry heterozygous pathogenic germline variants in mismatch repair (MMR) genes, which have also been shown to play an important role in meiosis. Therefore, it was hypothesized, that LS might be associated with a higher risk for premature ovarian failure (POF) or earlier menopause. Data on medical gynaecological history, cancer diagnoses and therapy were collected from 167 female LS patients and compared to a population-based control cohort. There was no difference between the age of menopause in patients compared to controls and no evidence for a higher risk of POF in LS patients. However, around one third (35%) of the probands have already had premenopausal cancer and mostly cancer-related treatment affecting fertility before the age of 45 years. Therefore, childbearing time might still be limited in these patients, especially due to the premenopausal cancer risk. LS patients should be informed in time about the elevated premenopausal cancer risks and the possible impact on family planning. This is particularly relevant since the average childbearing age has increased during the last decades.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"473-478"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139570136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome 一个家族中的 TP53 基因 p.R181H 变异,体现了李-弗劳米尼综合征基因型与表型的相关性
IF 2.2 4区 医学
Familial Cancer Pub Date : 2024-09-11 DOI: 10.1007/s10689-024-00419-7
Claire Freycon, Laura Palma, Crystal Budd, Frederic Coulombe, Leora Witkowski, Pierre Hainaut, William D. Foulkes, Catherine Goudie
{"title":"Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome","authors":"Claire Freycon, Laura Palma, Crystal Budd, Frederic Coulombe, Leora Witkowski, Pierre Hainaut, William D. Foulkes, Catherine Goudie","doi":"10.1007/s10689-024-00419-7","DOIUrl":"https://doi.org/10.1007/s10689-024-00419-7","url":null,"abstract":"<p>Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with germline pathogenic/likely pathogenic variants in <i>TP53</i>. Genotype-phenotype correlations are progressively being characterized in LFS with certain <i>TP53</i> variants associated with attenuated penetrance and phenotypes. We report on a family harboring a <i>TP53</i> p.R181H variant presenting with a restricted cancer phenotype in adulthood. The proband was a female with breast cancer at the age of 71 years who had three first degree relatives also diagnosed with breast cancer after the age of 40 years (mother, two sisters). Of the nine individuals harboring the variant (6 genetically confirmed, 3 obligate heterozygous), six have not developed malignancies at this time (age range: 36–42). No childhood-onset cancers were reported in this family. A concomitant literature review identified 51 additional individuals harboring the p.R181H variant in <i>TP53</i>, presenting a tumor phenotype dominated by breast cancer. Rare occurrences of other adult-onset cancers (prostate, colorectal and thyroid) and only few childhood onset cancer were documented. These observations are consistent with functional analysis showing that p.R181H retains partial p53 function and suggesting possible reduced cancer penetrance, particularly in the pediatric setting.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":"77 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1 通过内镜筛查识别 CDH1 基因致病变异携带者的标志环细胞胃癌病灶
IF 2.2 4区 医学
Familial Cancer Pub Date : 2024-09-11 DOI: 10.1007/s10689-024-00421-z
Lady Katherine Mejia Perez, Margaret O’Malley, Arjun Chatterjee, Ruishen Lyu, Qijun Yang, Michael W. Cruise, Lisa LaGuardia, David Liska, Carole Macaron, R. Matthew Walsh, Carol A. Burke
{"title":"Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1","authors":"Lady Katherine Mejia Perez, Margaret O’Malley, Arjun Chatterjee, Ruishen Lyu, Qijun Yang, Michael W. Cruise, Lisa LaGuardia, David Liska, Carole Macaron, R. Matthew Walsh, Carol A. Burke","doi":"10.1007/s10689-024-00421-z","DOIUrl":"https://doi.org/10.1007/s10689-024-00421-z","url":null,"abstract":"<p>To determine the preoperative detection of signet ring cancer cells (SRC) on upper endoscopy (EGD) in patients with <i>CDH1</i> pathogenic variant (PV) undergoing gastrectomy. To evaluate the development of advanced diffuse gastric cancer (DGC) in patients choosing surveillance. Guidelines recommend prophylactic total gastrectomy (pTG) in <i>CDH1</i> PV carriers with family history of DGC between 18 and 40 years. Annual EGD with biopsies according to established protocols is recommended in carriers with no SRC and no family history of DGC, with consideration of pTG. Retrospective analysis of asymptomatic patients with <i>CDH1</i> PVs with ≥ 1 surveillance EGD. Outcomes included pre-operative EGD detection of SRC, surgical stage, and progression to advanced DGC in those electing surveillance with EGD. 48 patients with <i>CDH1</i> PVs who had ≥ 1 EGD were included. 24/ 48 (50%) underwent gastrectomy, including pTG in 7 patients. SRCC were detected on gastrectomy specimen in 21/24 (87.5%). SRCs were identified by EGD in 17/21 patients who had SRCC on gastrectomy specimens (sensitivity 81%, 17/21). All cancers were stage pT1a. The remaining 17 patients (50% with a family history of gastric cancer) continue in annual EGD surveillance with a median follow-up of 34.6 months. No SRCC or advanced DGC have been diagnosed. No <i>CDH1</i> PV carriers without SRCC on random biopsies followed in an endoscopic program developed advanced DGC over a median follow up of 3 years. In the short term, EGD surveillance might be a safe alternative to immediate pTG in experienced hands in referral centers.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":"87 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review. 一名生殖系 BRCA2 变异携带者的胰腺尖细胞癌对铂和奥拉帕尼治疗的反应:病例报告和文献综述。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-08-01 Epub Date: 2024-05-11 DOI: 10.1007/s10689-024-00390-3
Hiroyuki Matsubayashi, Akiko Todaka, Takahiro Tsushima, Yoshimi Kiyozumi, Rina Harada, Eiko Ishihara, Satomi Higashigawa, Nobuyuki Ohike, Hiroki Sakamoto, Junya Sato, Hirotoshi Ishiwatari, Teichi Sugiura, Katsuhiko Uesaka
{"title":"The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review.","authors":"Hiroyuki Matsubayashi, Akiko Todaka, Takahiro Tsushima, Yoshimi Kiyozumi, Rina Harada, Eiko Ishihara, Satomi Higashigawa, Nobuyuki Ohike, Hiroki Sakamoto, Junya Sato, Hirotoshi Ishiwatari, Teichi Sugiura, Katsuhiko Uesaka","doi":"10.1007/s10689-024-00390-3","DOIUrl":"10.1007/s10689-024-00390-3","url":null,"abstract":"<p><p>A 73-year-old Japanese man with a history of distal biliary cancer treated by pancreatoduodenectomy developed pancreatic acinar cell carcinoma (PACC) treated by remnant pancreatectomy and adjuvant chemotherapy. Thirteen months after surgery, multiple liver metastases developed and FOLFOX chemotherapy was initiated. Based on the PACC diagnosis and a positive family history for breast and ovarian cancer genetic testing was performed which revealed a pathogenic germline BRCA2 variant (c.8629G > T, p.Glu2877Ter). Olaparib therapy was initiated and the metastases responded well (partial response). PACC is a BRCA2-associated cancer which may respond well to PARP inhibitors.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"393-398"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140908305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial pancreatic cancer: a long fruitful journey. 家族性胰腺癌:漫漫征途硕果累累。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-08-01 Epub Date: 2024-03-04 DOI: 10.1007/s10689-024-00364-5
Teresa A Brentnall
{"title":"Familial pancreatic cancer: a long fruitful journey.","authors":"Teresa A Brentnall","doi":"10.1007/s10689-024-00364-5","DOIUrl":"10.1007/s10689-024-00364-5","url":null,"abstract":"<p><p>In the early years of my GI fellowship, a healthy 40-year-old man came to my clinic and announced that he was going to die of pancreatic cancer. His brothers, father and uncles had all died of the disease; he felt his fate was inescapable. I asked whether his family members had seen doctors or had any tests. His answer was yes to both. Even so, doctors could not diagnose the pancreatic cancer at early stages. CT scans were always negative. I thought to myself, in order to help this patient-CT scans may not be reliable for early detection. Perhaps other methods of imaging the pancreas might be of more benefit. This patient opened a door that led to a 30-year journey of trying to detect pancreatic cancer at earlier stages when it is curable.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"217-220"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140021312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals. 意大利胰腺癌高危家庭登记处(IRFARPC):高危人群胰腺癌监测国家计划的实施与发展。
IF 1.8 4区 医学
Familial Cancer Pub Date : 2024-08-01 Epub Date: 2024-03-16 DOI: 10.1007/s10689-024-00366-3
Livia Archibugi, Fabio Casciani, Silvia Carrara, Erica Secchettin, Massimo Falconi, Gabriele Capurso, Salvatore Paiella
{"title":"The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals.","authors":"Livia Archibugi, Fabio Casciani, Silvia Carrara, Erica Secchettin, Massimo Falconi, Gabriele Capurso, Salvatore Paiella","doi":"10.1007/s10689-024-00366-3","DOIUrl":"10.1007/s10689-024-00366-3","url":null,"abstract":"<p><p>Screening programs for early detection and treatment of pancreatic cancer (PC) and its precursor lesions are increasingly implemented worldwide to reduce disease-specific lethality. Given the relatively low prevalence of the disease, the ideal target of such approaches is an enriched cohort of individuals harboring a lifetime risk of developing PC significantly higher compared to the general population, given either a substantial aggregation of PC cases in their family (i.e. familial pancreatic cancer) or a genomic landscape enriched with pathogenic variants associated with pancreatic carcinogenesis (i.e. mutation carriers). In Italy, a national registry for the census and surveillance of high-risk individuals for PC was launched in 2015, enrolling some 1200 subjects as of today. In this perspective, the scientific background, multi-level structure, and evolution of IRFARPC are outlined, as well as its long-term results, future developments, and areas for improvement.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"373-382"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140140105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信